Application of black phosphorus nanosheet

By using black phosphorus nanosheets as nanomedicine, the problems of ovarian aging and degradation of oocyte quality were solved, and the effects of reversing ovarian cell aging and enhancing oocyte function were achieved, demonstrating excellent biocompatibility and safety.

CN118892498APending Publication Date: 2024-11-05GUIZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410950924.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

As humans age, ovarian aging and oocyte quality decrease, resulting in a decrease in fertility. The existing technology lacks effective therapeutic strategies.

Method used

Black phosphorus nanosheets are developed as nanodrugs, which are administered through intraperitoneal injection or oral administration, to improve ovarian aging and improve oocyte quality, inhibit ovarian interstitial cell fibrosis, activate autophagy, and improve estrus cycle and hormone levels.

Benefits of technology

Black phosphorus nanosheets can reverse ovarian cell aging, inhibit granule cell death, enhance proliferation, improve oocyte quality, and show biocompatibility and safety for organs such as the heart, liver, spleen, lungs, and kidneys.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004947213430000051
    Figure BDA0004947213430000051
  • Figure BDA0004947213430000052
    Figure BDA0004947213430000052
  • Figure HDA0004947213440000011
    Figure HDA0004947213440000011
Patent Text Reader

Abstract

The invention relates to application of a black phosphorus nanosheet. The black phosphorus nanosheet is applied to preparation of nano-drugs for improving ovarian aging and improving the quality of aged oocytes, on one hand, ovarian aging is delayed and the hormone level is maintained by relieving ovarian interstitial cell fibrosis and reducing granular cell apoptosis; on the other hand, the quality of the aged oocytes is improved by promoting oocyte autophagy; meanwhile, no obvious biological cytotoxic effect is generated on cells and tissues, and excellent biocompatibility and safety are shown.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical application technology, and in particular to an application of black phosphorus nanosheets. Background Art

[0002] Human fertility and reproductive lifespan decline dramatically with age, especially after the mid-1930s. Approximately 10% of prospective parents are unable to achieve natural childbearing before the age of 34, but this proportion increases to 87% in women over the age of 45. Older women may experience an increased risk of infertility, spontaneous abortion, perinatal death, and congenital anomalies. Although assisted reproductive technology can compensate for suboptimal reproductive outcomes in humans to some extent, the success rate of assisted reproductive technology cycles also decreases with age. The live birth rate of female patients undergoing in vitro fertilization under the age of 35 is 41% to 43%, while this proportion drops to 1% to 2% when they reach 44 years of age and above. This tendency is mainly closely related to ovarian aging and decreased oocyte quality with age. However, there is still a lack of effective treatment strategies for the cause of ovarian aging and decreased oocyte quality in clinical practice.

[0003] To solve this problem, new drugs and new application methods must be developed to improve ovarian aging and improve oocyte quality. Impaired autophagy is an important feature of aging, and autophagic activity decreases with age. Studies in Caenorhabditis elegans, rodents, and human cells have shown that lysosomal proteolytic function decreases with age, impairing autophagic flux, aggravating cell damage, and promoting the development of aging-related diseases. Impaired autophagy can also disrupt tissue homeostasis. Impaired lysosomal fusion or degradation is the cause of aging-related autophagy disorders, resulting in cell dysfunction and cell death. Therefore, increasing the level of autophagy in the ovary and promoting oocyte autophagy are of great significance for the treatment of ovarian aging and decreased oocyte quality.

[0004] Black phosphorus (BP) is the most stable allotrope of phosphorus. Black phosphorus nanosheets (BPNSs) are a new type of two-dimensional nanomaterial composed of single-layer or multi-layer flaky black phosphorus, which has many good properties. Black phosphorus nanosheets are mainly composed of phosphorus elements, which are degraded into biocompatible ions such as phosphite ions and phosphate ions in the body. They have no obvious biological cytotoxic effects on cells and tissues, and show excellent biocompatibility and safety. Black phosphorus nanosheets also have strong reactive oxygen species (ROS) scavenging ability, good antioxidant properties and high surface area ratio, making them suitable as drug carriers. The development and construction of nanomedicines for improving autophagy using black phosphorus nanosheets provides new ideas for the development of clinical drugs for ovarian aging.

[0005] Based on this, the present invention rationally develops black phosphorus nanosheets as a therapeutic drug for improving ovarian aging and improving oocyte quality. Summary of the invention

[0006] The purpose of the invention is to provide an application of black phosphorus nanosheets.

[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0008] The invention discloses an application of a black phosphorus nanosheet in preparing a nano drug for improving ovarian aging and improving the quality of aged oocytes.

[0009] The black phosphorus nanosheets are used in the preparation of drugs for improving oocyte quality and promoting endocrine homeostasis.

[0010] The black phosphorus nanosheets are used in the preparation of drugs for inhibiting ovarian interstitial cell fibrosis.

[0011] The dosage of the black phosphorus nanosheets is 0.5 to 3 mg per kg of the subject.

[0012] Preferably, the dosage of the black phosphorus nanosheets is 1 mg per kg of the subject.

[0013] The black phosphorus nanosheets of the present invention are added with pharmaceutically acceptable excipients to prepare a pharmaceutically acceptable dosage form.

[0014] The dosage form can be a solid preparation, and the solid preparation is a tablet, a capsule, or a granule.

[0015] The dosage form may also be a liquid preparation, and the liquid preparation is an injection or an oral solution.

[0016] The concentration range of the black phosphorus nanosheets in the injection solution is 500 to 850 ug / mL.

[0017] Preferably, the concentration of black phosphorus nanosheets in the injection solution is 750 ug / mL.

[0018] The black phosphorus nanosheets were administered by intraperitoneal injection, with a dose of 1 mg of black phosphorus nanosheets per kg of the subject.

[0019] The black phosphorus nanosheets are administered orally, and the dosage is 2 mg per kg of the subject.

[0020] The ovarian aging and oocyte quality decline described are symptoms due to natural aging.

[0021] The preparation method of black phosphorus nanosheets is as follows: 500 mg of red phosphorus, 20 mg of Sn powder, and 10 mg of SnI4 are vacuum-sealed in a quartz tube with an inner diameter of 1 cm. The quartz tube is placed horizontally in the middle of a vacuum tube furnace, and the temperature is raised to 923K at a rate of 2°C / min and heated for 5 hours. Then the temperature is lowered to 773K at a rate of 0.33°C / min and heated for 2 hours. Then it is naturally cooled to room temperature. The mixture is heated to reflux until Sn dissipates and the solution turns orange, indicating that the reaction is complete. After cooling, the crude product crystallizes as an orange solid and is further purified by recrystallization from hot chloroform. The obtained sample is ultrasonically treated with the probe ultrasonic tip at an ultrasonic frequency of 19 to 25 kHz for 5 seconds and 2 seconds at intervals for 4 hours to remove by-products and obtain pure BP crystals; 100 mg of BP powder is dispersed in 20 mL of anhydrous ethanol and placed in a 50 mL sealed stainless steel ball mill. Add 100 g of grinding balls with diameters of 10 mm and 5 mm, each accounting for 50%. The mixture was ground on a ball mill at 600 rpm for 6 h, the resulting dispersion was centrifuged at 12,000 rpm for 20 min, and the precipitate was discarded to obtain a supernatant containing BPNSs, and then centrifuged at 35,000 rpm to obtain the black phosphorus nanosheets.

[0022] The black phosphorus nanosheets prepared by the preparation method are unmodified black phosphorus nanosheets with a size of 50 to 60 nm.

[0023] Beneficial Effects

[0024] 1. Black phosphorus nanosheets can inhibit ovarian interstitial cell fibrosis and reverse ovarian cell aging.

[0025] 2. Black phosphorus nanosheets can inhibit granulosa cell death and enhance granulosa cell proliferation.

[0026] 3. Black phosphorus nanosheets can improve the estrus cycle and maintain hormone levels.

[0027] 4. Black phosphorus nanosheets can improve the quality of aging oocytes and activate oocyte autophagy.

[0028] 5. Black phosphorus nanosheets have no obvious biological cytotoxicity to cells and tissues of the heart, liver, spleen, lungs, and kidneys, and exhibit excellent biocompatibility and safety. They can be used to prepare nanomedicines to improve ovarian aging and improve the quality of aged oocytes. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 The transmission electron microscopy results of black phosphorus nanosheets prepared in Experimental Example 1, A is the transmission electron microscopy image, and B is the particle size distribution diagram;

[0030] Figure 2 This is the upright microscope image of Test Example 2;

[0031] Figure 3 This is the upright microscope image of Test Example 3;

[0032] Figure 4 This is the laser confocal microscope image of Experimental Example 4;

[0033] Figure 5 This is the laser confocal microscope image of Experimental Example 5;

[0034] Figure 6 This is a line graph of the estrus cycle of mice in Experimental Example 6;

[0035] Figure 7 This is the laser confocal microscope image of Experimental Example 7;

[0036] Figure 8 This is the laser confocal microscope image of Experimental Example 8;

[0037] Fig. 9 This is an upright microscope image of Experimental Example 9.

[0038] Caption of the attached figure:

[0039] Control was the control group, Old was the aged mouse group, and Old+BPNSs and BPNSs were the black phosphorus nanosheet intervention groups;

[0040] Estrus is the estrus period, Proestrus is the proestrus period, Dioestrus is the diestrus period, and Metaestrus is the metestrus period. DETAILED DESCRIPTION

[0041] The present invention is further described in detail below in conjunction with embodiments, test examples and drawings, but the embodiments of the present invention are not limited thereto.

[0042] Unless otherwise defined, all scientific and technical terms used in the present invention have the same meanings as commonly understood by one of ordinary skill in the art to which the present invention relates.

[0043] In order to have a clearer understanding of the technical features, purposes and beneficial effects of the present invention, the technical solution of the present invention is now described in detail below, but it should not be construed as limiting the applicable scope of the present invention.

[0044] Example 1 Preparation of black phosphorus nanosheets

[0045] 500mg of red phosphorus, 20mg of Sn powder, and 10mg of SnI4 were vacuum-sealed in a quartz tube with an inner diameter of 1cm. The quartz tube was placed horizontally in the middle of a vacuum tube furnace, and the temperature was raised to 923K at a rate of 2℃ / min and heated for 5h. Then the temperature was lowered to 773K at a rate of 0.33℃ / min and heated for 2h. Then it was cooled naturally to room temperature. The mixture was heated to reflux until Sn dissipated and the solution turned orange, indicating that the reaction was complete. After cooling, the crude product crystallized into an orange solid and was further purified by recrystallization from hot chloroform. The obtained sample was ultrasonically treated with the probe ultrasonic tip at a frequency of 24kHz, and the mixed solution was ultrasonically treated for 4h every 5s and 2s at intervals to remove by-products and obtain pure BP crystals; 100mg of BP powder was dispersed in 20mL of anhydrous ethanol and placed in a 50mL sealed stainless steel ball mill. 100g of grinding balls with diameters of 10mm and 5mm, each accounting for 50%, were added. The mixture was ground on a ball mill at 600 rpm for 6 h, the resulting dispersion was centrifuged at 12,000 rpm for 20 min, and the precipitate was discarded to obtain a supernatant containing BPNSs, and then centrifuged at 35,000 rpm to obtain the black phosphorus nanosheets.

[0046] Example 2 Preparation of black phosphorus nanosheet tablets

[0047] The black phosphorus nanosheets are used as raw materials, 3 times the amount of soluble medicinal starch is added, the mixture is evenly mixed, and tablets are pressed to obtain tablets.

[0048] Example 3 Preparation of black phosphorus nanosheet capsules

[0049] The black phosphorus nanosheets are used as raw materials, 5 times the amount of soluble medicinal starch is added, the mixture is evenly mixed, filled into capsules, and polished to obtain capsules.

[0050] Example 4 Preparation of black phosphorus nanosheet granules

[0051] The black phosphorus nanosheets are used as raw materials, 5 times the amount of soluble medicinal starch is added, the mixture is evenly mixed, and granules are prepared to obtain granules.

[0052] Example 5 Preparation of black phosphorus nanosheet injection

[0053] Take black phosphorus nanosheets as raw materials, add 25 times the amount of injection water, mix evenly, filter and sterilize to obtain the injection.

[0054] Example 6 Preparation of black phosphorus nanosheet oral solution

[0055] Take black phosphorus nanosheets as raw material, add 20 times amount of pure water, mix evenly, filter, sterilize and bottle to obtain oral solution.

[0056] Example 7

[0057] The black phosphorus nanosheets are administered by intraperitoneal injection, and the dosage is 1 mg per kg of the subject.

[0058] Example 8

[0059] The black phosphorus nanosheets are administered orally, and the dosage is 2 mg per kg of the subject.

[0060] In order to further verify the effectiveness of the present invention, the inventors conducted a series of verification experiments, the excerpts of which are as follows: The reagents and equipment used in the experiments are shown in Tables 1 and 2.

[0061] Table 1 Main consumables and reagents

[0062]

[0063] Table 2 Main instruments and equipment

[0064]

[0065] Experimental Example 1 Preparation method of black phosphorus nanosheets

[0066] The preparation method of black phosphorus nanosheets is as follows: 500 mg of red phosphorus, 20 mg of Sn powder, and 10 mg of SnI4 are vacuum-sealed in a quartz tube with an inner diameter of 1 cm. The quartz tube is placed horizontally in the middle of a vacuum tube furnace, and the temperature is raised to 923K at a rate of 2°C / min and heated for 5 hours. Then the temperature is lowered to 773K at a rate of 0.33°C / min and heated for 2 hours. Then it is naturally cooled to room temperature. The mixture is heated to reflux until Sn dissipates and the solution turns orange, indicating that the reaction is complete. After cooling, the crude product crystallizes as an orange solid and is further purified by recrystallization from hot chloroform. The obtained sample is ultrasonically treated with a probe ultrasonic tip at a frequency of 24kHz, and the mixed solution is ultrasonically treated for 4 hours at intervals of 2 seconds for every 5 seconds of operation to remove by-products and obtain pure BP crystals; 100 mg of BP powder is dispersed in 20 mL of anhydrous ethanol and placed in a 50 mL sealed stainless steel ball mill. Add 100 g of grinding balls with diameters of 10 mm and 5 mm, each accounting for 50%. Grind at 600 rpm on a ball mill for 6 hours; centrifuge the resulting dispersion at 12,000 rpm for 20 minutes, discard the precipitate, and obtain a supernatant containing BPNSs. Then centrifuge at 35,000 rpm, weigh the precipitate, add anhydrous ethanol or physiological saline for ultrasonic dispersion according to experimental needs, and prepare a 1-4 mg / mL black phosphorus nanosheet solution. Figure 1 The transmission electron microscopy results of the black phosphorus nanosheets prepared in this experiment show that the black phosphorus nanosheets prepared in the present invention have a transmission electron microscopy size mainly in the range of 50 to 60 nm and a uniform particle size distribution.

[0067] Experimental Example 2: Black phosphorus nanosheets inhibit ovarian interstitial cell fibrosis

[0068] Ovaries of drug-injected mice were collected and fixed with 4% paraformaldehyde for 12-24 hours, dehydrated with gradient of 70% ethanol-80% ethanol-95% ethanol-95% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene to make them transparent, immersed in wax in a 60°C water bath overnight, embedded in wax, cut into slices with a microtome, and baked at 42°C overnight. Ovarian slices were dewaxed and rehydrated with gradient of xylene-xylene-anhydrous ethanol-anhydrous ethanol-90% ethanol-80% ethanol-70% ethanol, and washed with PBS buffer 3 times, 5 minutes each time.

[0069] The sections were dewaxed and rehydrated, washed with PBS buffer, circled the tissue range with a histochemical pen, and stained with about 100-200 μl Weigert hematoxylin for 4 minutes; differentiated with acidic ethanol differentiation solution for 15 seconds, transferred to tap water for washing for 1 minute; bluing with Masson blue solution for 4 minutes, washing with tap water for 1 minute, and washing with ultrapure water for 1 minute; staining with Ponceau red solution for 20 seconds, washing with weak acid working solution for 1 minute, and washing with ultrapure water for 1 minute; staining with phosphomolybdic acid staining solution for 2 minutes, washing with weak acid working solution for 1 minute; staining with aniline blue for 2 minutes, washing with weak acid working solution for 1 minute; microscopic examination; 70% ethanol-80% ethanol-90% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene gradient dehydration to make it transparent, and sealing with neutral gum. The ovarian fibrosis was observed using an upright microscope.

[0070] Figure 2 This is an upright microscope image of this experimental example. It can be seen that the fibrosis of ovarian interstitial cells in the Old mouse model is more serious than that in the normal mice in the control group. After the intervention of black phosphorus nanosheets, the fibrosis of ovarian interstitial cells in the Old mice was significantly alleviated.

[0071] Experimental Example 3: Black phosphorus nanosheets reverse ovarian aging

[0072] Ovaries of drug-injected mice were collected and frozen at -80°C. Ovaries were embedded with cryosection embedding agent, frozen sections were stored at -20°C. When β-gal staining was performed, the sections were taken out from -20°C and equilibrated at room temperature for 30 minutes; the tissues were washed with PBS buffer 3 times, each time for 10 minutes; the β-gal staining fixative was fixed at room temperature for 1.5 hours; the tissues were washed with PBS buffer 3 times, each time for 10 minutes; the β-gal staining working solution was stained in a 37°C wet box overnight; the tissues were washed with 70% ethanol for 40 minutes, and then washed with PBS buffer 2 times, each time for 10 minutes; the tissues were sealed with sealing solution. The aging of ovarian cells was observed using an upright microscope.

[0073] Figure 3 This is an upright microscope image of this experimental example. It can be seen that the ovarian cells in the Old mouse model are severely aged, and the intervention of black phosphorus nanosheets can improve the aging of the ovarian cells in the Old mice.

[0074] Experimental Example 4: Black phosphorus nanosheets inhibit granulocyte cell death

[0075] Ovaries of drug-injected mice were collected and fixed with 4% paraformaldehyde for 12-24 hours, dehydrated with gradient of 70% ethanol-80% ethanol-95% ethanol-95% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene to make them transparent, immersed in wax in a 60°C water bath overnight, embedded in wax, cut into slices with a microtome, and baked at 42°C overnight. Ovarian slices were dewaxed and rehydrated with gradient of xylene-xylene-anhydrous ethanol-anhydrous ethanol-90% ethanol-80% ethanol-70% ethanol, and washed with PBS buffer 3 times, 5 minutes each time.

[0076] The sections were dewaxed and rehydrated, washed with PBS buffer, replaced with antigen repair solution, and repaired under high pressure for 20 minutes; washed with PBS buffer twice, 5 minutes each time; prepared proteinase K, digested in a 37℃ wet box incubator for 25 minutes; washed with PBS buffer three times, 10 minutes each time; prepared TUNEL staining solution and added DAPI (1:1000), circled the tissue range with a histochemical pen, took about 200μl and dropped it on the tissue, stained in a 37℃ incubator for 60 minutes; washed with PBS buffer 4 times, 15 minutes each time; sealed with anti-fluorescence quenching sealing agent. Ovarian cell apoptosis was observed with laser confocal microscopy.

[0077] Figure 4 This is a laser confocal microscope image, which shows that the ovarian cell apoptosis in the Old mouse model is serious, and the intervention of black phosphorus nanosheets can alleviate the apoptosis of ovarian cells in Old mice.

[0078] Experimental Example 5 Black phosphorus nanosheets enhance granulocyte proliferation

[0079] Ovaries of drug-injected mice were collected and fixed with 4% paraformaldehyde for 12-24 hours, dehydrated with gradient of 70% ethanol-80% ethanol-95% ethanol-95% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene to make them transparent, immersed in wax in a 60°C water bath overnight, embedded in wax, cut into slices with a microtome, and baked at 42°C overnight. Ovarian slices were dewaxed and rehydrated with gradient of xylene-xylene-anhydrous ethanol-anhydrous ethanol-90% ethanol-80% ethanol-70% ethanol, and washed with PBS buffer 3 times, 5 minutes each time.

[0080] The sections were dewaxed and rehydrated, washed with PBS, replaced with antigen repair solution, and repaired under high pressure for 20 minutes; washed with PBS twice, 5 minutes each time; circled the tissue range with a histochemical pen, and added about 200 μl of 5% bovine serum albumin (BSA) to block in a wet box at room temperature for 2 hours; diluted the primary antibody Ki67 according to the proportion, removed BSA, added the primary antibody, and kept in a wet box at 4°C overnight; washed the primary antibody with PBS, washed twice, 20 minutes each time; diluted the secondary antibody and DAPI according to the proportion, added to the tissue, and incubated at 37°C in the dark for 1 hour; washed the secondary antibody with PBS buffer, washed 5 times, 20 minutes each time; microscopic examination; anti-fluorescence quenching sealing agent was used to seal the sections. The proliferation of ovarian cells was observed with a laser confocal microscope.

[0081] Figure 5 This is a laser confocal microscope image of this embodiment. The proliferation process of ovarian cells in the Old mouse model is abnormal. After the intervention of black phosphorus nanosheets, the proliferation process of ovarian cells in the Old mouse returned to normal.

[0082] Experimental Example 6: Black phosphorus nanosheets improve estrus cycle detection in aging mice

[0083] Take 50μl of sterile saline with a pipette, gently insert the pipette tip into the vaginal opening of the mouse, and gently rinse the vaginal opening 4-5 times; evenly apply the mouse vaginal rinsing liquid on the slide, and bake the slide at 42℃; fix the slide with anhydrous ethanol at room temperature for 10min; immerse the slide in hematoxylin staining solution, stain for 30s, wash the slide with tap water 3-4 times until there is no blue liquid in the staining jar, and examine under a microscope; immerse the slide in eosin staining solution, stain for 2min, wash the slide with tap water 3-4 times, and examine under a microscope. Observe the cell composition of the vaginal smear under a microscope to determine the estrus cycle stage of the mouse.

[0084] Figure 6 This is the line graph of the estrus cycle of mice in this experiment. The estrus cycle of mice in the NC group is regular, and the estrus cycle of Old mice is blocked for a long time at a certain period. After the intervention of black phosphorus nanosheets, the estrus cycle of Old mice gradually returned to regularity.

[0085] Experimental Example 7: Detection of black phosphorus nanosheets activating autophagy

[0086] After superovulation, the oocytes were removed and fixed with 4% paraformaldehyde for 1 hour; the oocytes were transferred to a drop of demembranation solution for permeabilization at room temperature for 30 minutes; the oocytes were washed with 5% BSA blocking solution for 10 minutes, and after washing, they were transferred to a new blocking solution for blocking at room temperature for 1 hour; the primary antibody LC3B was prepared in proportion, and after blocking, the oocytes were incubated with the primary antibody in a 4°C wet box overnight. The primary antibody was washed with elution solution 3 times, 20 minutes each time; the secondary antibody and DAPI were prepared in proportion, and the oocytes were incubated in a wet box at room temperature for 2 hours in the dark; the secondary antibody was washed with elution solution 5 times, 20 minutes each time; the anti-fluorescence quenching sealing agent was used to seal the slices. Oocyte autophagy was observed with a laser confocal microscope.

[0087] Figure 7 This is the laser confocal microscopy image of this experimental example. It can be seen that the autophagy level of the oocytes of the Old mouse model is decreased, and the autophagy level of the oocytes of the Old mouse is increased after the intervention of black phosphorus nanosheets.

[0088] Experimental Example 8 Fluorescence detection of black phosphorus nanosheets improving the quality of oocytes in aged mice

[0089] 46 hours after PMSG was injected intraperitoneally in mice, hCG was injected 12 hours later; mice were killed by cervical dislocation, the ampulla of the oviduct was found, the bulge was cut, and the cumulus-oocyte mass flowed out. The cumulus-oocyte mass was transferred to a droplet made of hyaluronic acid, the cumulus cells were digested, and the oocytes were transferred to a droplet of complete culture medium to terminate digestion, and the remaining cumulus cells were washed three times in a new complete culture medium. Transfer to 4% paraformaldehyde for fixation for 1 hour; the oocytes were transferred to a droplet of demembranation solution for permeabilization at room temperature for 30 minutes; the oocytes were washed with 5% BSA blocking solution for 10 minutes, and after washing, they were transferred to a new blocking solution for blocking at room temperature for 1 hour; the primary antibody α-Tubulin was prepared in proportion, and after blocking, the oocytes were incubated with the primary antibody in a 4℃ wet box overnight. The primary antibody was washed with elution solution 3 times, 20 minutes each time; the secondary antibody and DAPI were prepared in proportion, and the oocytes were incubated in a wet box at room temperature in the dark for 2 hours; the secondary antibody was washed with elution solution 5 times, 20 minutes each time; the anti-fluorescence quenching sealing agent was used to seal the slides. Laser confocal microscopy was used to observe the abnormalities of oocyte chromosomes and spindles.

[0090] Figure 8 This is a laser confocal microscope image of this embodiment. It can be seen that the chromosomes of the oocytes of the Old mouse model are misaligned, the metaphase plate width is abnormal, and the spindle is abnormal. The intervention of black phosphorus nanosheets can improve the chromosome misalignment and spindle abnormalities of the oocytes of the Old mouse.

[0091] Experimental Example 9 Effects of Black Phosphorus Nanosheets on Various Organs of Mice

[0092] The black phosphorus nanosheets were injected into mice, and the heart, liver, spleen, lung, and kidney were removed and fixed in 4% paraformaldehyde for 24 to 48 hours, and then dehydrated and made transparent in a gradient of 70% ethanol-80% ethanol-95% ethanol-95% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene. The slices were immersed in wax overnight in a 60°C water bath, embedded in wax, and quickly fixed. The slices were sliced ​​with a microtome and baked overnight at 42°C. Ovarian slices were dewaxed and rehydrated in a gradient of xylene-xylene-anhydrous ethanol-anhydrous ethanol-90% ethanol-80% ethanol-70% ethanol, and washed with PBS three times, each time for 5 minutes. The slices were placed in hematoxylin stain for 20 seconds, the excess stain was rinsed with tap water, and the slices were transferred to eosin stain for 1 minute. After microscopic examination, the slices were dehydrated and made transparent in a gradient of 70% ethanol-80% ethanol-90% ethanol-anhydrous ethanol-anhydrous ethanol-xylene-xylene, and sealed with neutral gum. The HE staining results of each organ were observed under an upright microscope.

[0093] Fig. 9 This is an upright microscope image of this embodiment. It can be seen that after the injection of black phosphorus nanosheets, the ovaries, heart, liver, spleen, lungs, and kidneys of mice have normal morphology and no obvious toxicity.

Claims

1. Application of black phosphorus nanosheets in the preparation of nanomedicines for improving ovarian aging and improving the quality of aging oocytes.

2. The use according to claim 1, characterized in that The black phosphorus nanosheets are used in the preparation of drugs for improving oocyte quality.

3. The use according to claim 1, characterized in that Application of the black phosphorus nanosheets in the preparation of drugs for promoting endocrine homeostasis.

4. The use according to claim 1, characterized in that The black phosphorus nanosheets are used in the preparation of drugs for inhibiting ovarian interstitial cell fibrosis.

5. The use according to claim 1, characterized in that The black phosphorus nanosheets are added with pharmaceutically acceptable excipients to prepare a pharmaceutically acceptable dosage form.

6. The use according to claim 4, characterized in that The dosage form is a solid preparation or a liquid preparation.

7. The use according to claim 5, characterized in that The solid preparation is tablet, capsule or granule.

8. The use according to claim 5, characterized in that The liquid preparation is an injection or an oral solution.

9. The use according to claim 5, characterized in that The black phosphorus nanosheets are administered by intraperitoneal injection, and the dosage of the black phosphorus nanosheets is 1 mg per kg of the subject.

10. The use according to claim 5, characterized in that The black phosphorus nanosheets are administered orally, and the dosage is 2 mg per kg of the subject.